As previously discussed, PD-L1 expression, even in a small percentage of tumor cells, is postulated as a predictive marker for anti-tumor response of anti-PD-1 and anti-PD-L1 treatment, but evidence is not conclusive, since published results appear contradictory. The gene discussed is CD274; the disease is neoplasm.